Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Because primary antifungal prophylaxis is widely used for immunocompromised hosts, the incidences of unusual fungal infections have increased. Trichosporon asahii has emerged as an important life-threatening opportunistic systemic pathogen because of the increased use of cytotoxic or immunosuppressant agents, along with high mortality rates. Here, we describe a case of catheter-related T. asahii bloodstream infection with multiple septic skin nodules in both the arms and legs of the patient who was in the neutropenic period after allogeneic stem cell transplantation for myelodysplastic syndrome treated with prophylactic ciprofloxacin and itraconazole. We successfully treated her with intravenous voriconazole for more than a month without any complications. Clinicians should consider breakthrough Trichosporon infections when clinical progress in an immunocompromised patient with unexplained infection signs and symptoms does not improve despite proper treatment with antibiotics or various antifungal agents. In addition, voriconazole can be a good treatment choice for achieving better treatment results and prognosis.
Abstract
Because primary antifungal prophylaxis is widely used for immunocompromised hosts, the incidences of unusual fungal infections have increased. Trichosporon asahii has emerged as an important life-threatening opportunistic systemic pathogen because of the increased use of cytotoxic or immunosuppressant agents, along with high mortality rates. Here, we describe a case of catheter-related T. asahii bloodstream infection with multiple septic skin nodules in both the arms and legs of the patient who was in the neutropenic period after allogeneic stem cell transplantation for myelodysplastic syndrome treated with prophylactic ciprofloxacin and itraconazole. We successfully treated her with intravenous voriconazole for more than a month without any complications. Clinicians should consider breakthrough Trichosporon infections when clinical progress in an immunocompromised patient with unexplained infection signs and symptoms does not improve despite proper treatment with antibiotics or various antifungal agents. In addition, voriconazole can be a good treatment choice for achieving better treatment results and prognosis.
참고문헌 (20)
- Malani AN, "Changing epidemiology of rare mould infections: implications for therapy", Drugs, 67, pp.1803~1812 (2007)[DOI]
- Auberger J, "Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in highrisk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study", J Antimicrob Chemother, 67, pp.2268~2273 (2012)[DOI]
- 강승훈, "Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis", Infection and Chemotherapy, 47(1), pp.49~54 (2015), 대한감염학회
- Bayramoglu G, "Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin", Infection, 36, pp.68~70 (2008)[DOI]
- Asada N, "Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia", Clin Infect Dis, 43, pp.e39~e41 (2006)[DOI]
- Clinical and Laboratory Standards Institute, "Reference method for broth dilution antifungal susceptibility testing of yeast; 4th informational supplement", CLSI, ~ (2012)
- Colombo AL, "Current knowledge of Trichosporon spp. and Trichosporonosis", Clin Microbiol Rev, 24, pp.682~700 (2011)[DOI]
- Arendrup MC, "ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections", Clin Microbiol Infect, 20(Suppl 3), pp.76~98 (2014)
- Dua V, "Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant", J Pediatr Hematol Oncol, 35, pp.237~238 (2013)
- Ruan SY, "Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan", Clin Infect Dis, 49, pp.e11~e17 (2009)[DOI]
- Liao Y, "Serum glucuronoxylomannan may be more appropriate for the diagnosis and therapeutic monitoring of Trichosporon fungemia than serum -D-glucan", Int J Infect Dis, 16, pp.e638~ (2012)[DOI]
- Suzuki K, "Fatal Trichosporon fungemia in patients with hematologic malignancies", Eur J Haematol, 84, pp.441~447 (2010)[DOI]
- Menezes EA, "Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceara, Brazil", Rev Inst Med Trop Sao Paulo, 54, pp.1~3 (2012)
- Nachbaur D, "Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study", Eur J Haematol, 94, pp.258~264 (2015)[DOI]
- Chen J, "Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole", Med Mycol Case Rep, 6, pp.55~57 (2014)[DOI]
- Kim YJ, "Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient", Ann Clin Lab Sci, 37, pp.366~369 (2007)
- Rieger C, "Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia", Eur J Clin Microbiol Infect Dis, 26, pp.843~845 (2007)[DOI]
- 장문주, "급성골수성백혈병 환자에서Amphotericin B와 Fluconazole로 치료된 Trichosporon beigelii진균혈증 1례", Blood Research, 39(2), pp.109~112 (2004), 대한혈액학회
- Shimono J, "Acute renal tubular damage caused by disseminated Trichosporon infection in primary myelofibrosis", Rinsho Ketsueki, 56, pp.21~24 (2015)
- Matsue K, "Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin", Clin Infect Dis, 42, pp.753~757 (2006)[DOI]